Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | CLDN4 |
| Gene Name: | CLDN4 |
| Protein Full Name: | Claudin-4 |
| Alias: | CLD4; CLDN4; Clostridium perfringens enterotoxin receptor; Clostridium perfringens enterotoxin receptor 1; CPE- receptor; CPER; CPE-R; CPETR; CPETR1; WBSCR8; Williams-Beuren syndrome chromosomal region 8 protein; Williams-Beuren syndrome chromosome region 8 protein |
| Mass (Da): | 22077 |
| Number AA: | 209 |
| UniProt ID: | O14493 |
| Locus ID: | 1364 |
| COSMIC ID: | CLDN4 |
| Gene location on chromosome: | 7q11.23 |
| Cancer protein type: | UNCLEAR |
| Effect of cancer mutation on protein: | UNCLEAR (no mutations found) |
| Effect of active protein on cancer: | UNCLEAR |
| Number of cancer specimens: | 19625 |
| Percent of cancer specimens with mutations: | 0.18 |
| Mutations observed as inherited: | NA |
| Found in amplified chromosomal regions in human cancers: | NA |
| Deregulated in translocations: | NA |
| Deregulated by viral insertion: | NA |
| Transduced into viral genome: | NA |
| Gene undergoes hypermethylation: | NA |
| Normal role description: | CLDN4 is a transmembrane protein that plays a major role in tight junction formation and function. It appears to be overexpressed in pancreatic, breast, ovarian, and prostate cancer, but downregulated in gastric cancer. |